Walleye Capital’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.54M Buy
26,600
+13,700
+106% +$1.32M 0.01% 1318
2026
Q1
$1.34M Sell
12,900
-118,100
-90% -$13.4M 0.01% 1813
2025
Q4
$13.2M Buy
131,000
+84,700
+183% +$9.2M 0.04% 480
2025
Q3
$5.71M Buy
46,300
+9,900
+27% +$1.23M 0.02% 847
2025
Q2
$4.37M Buy
36,400
+17,400
+92% +$2.32M 0.02% 958
2025
Q1
$2.8M Sell
19,000
-5,000
-21% -$764K 0.01% 1195
2024
Q4
$3.9M Sell
24,000
-23,000
-49% -$3.76M 0.01% 1253
2024
Q3
$7.66M Sell
47,000
-13,500
-22% -$2M 0.02% 863
2024
Q2
$8.26M Sell
60,500
-13,800
-19% -$1.92M 0.01% 898
2024
Q1
$11.4M Sell
74,300
-8,200
-10% -$1.22M 0.02% 759
2023
Q4
$11.8M Buy
82,500
+32,100
+64% +$4.28M 0.02% 591
2023
Q3
$6.61M Buy
50,400
+38,300
+317% +$5.82M 0.02% 846
2023
Q2
$1.92M Buy
12,100
+5,200
+75% +$839K 0.01% 1362
2023
Q1
$1.09M Buy
6,900
+4,800
+229% +$720K 0.02% 1100
2022
Q4
$295K Hold
2,100
0.01% 1796
2022
Q3
$270K Buy
+2,100
New +$303K 0.01% 1903

Other funds holding CLX

Walleye Capital's CLX Position: Q2 2026 in Review

Walleye Capital increased its Clorox (CLX) stake by 23% in Q2 2026, buying an estimated $174K and bringing the position to 9,769 shares worth $932K. The position accounts for ﹤0.01% of the portfolio, ranked #2188.

Walleye Capital first reported a position in CLX in Q3 2021 and has held it in 16 quarters since. The position peaked at $3.68M in Q2 2024. 1,051 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Walleye Capital held 9,769 shares of Clorox worth $932K as of Q2 2026.
  • Walleye Capital bought 1,817 Clorox shares in Q2 2026, an estimated $174K.
  • Clorox made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2188 holding.
  • Walleye Capital first reported a position in Clorox in Q3 2021 and has held it in 16 quarters since.
  • Walleye Capital's Clorox position peaked at $3.68M in Q2 2024.
  • 1,051 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.